Kate Haviland

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Melissa Masse, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kate Haviland:

Company Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Chief Executive Officer, Director Stock Option (Right to Buy) 0 $2,537,920 $36.05 17 Jul 2025 Direct
Bicara Therapeutics Inc. Director Common Stock 7,437 $98,491 $13.24 12 Sep 2024 Direct
Blueprint Medicines Corp Chief Executive Officer, Director Common Stock 0 $0 $128.18 17 Jul 2025 Direct
Fulcrum Therapeutics, Inc. Director Stock Option (right to buy) 36,000 26 Jun 2025 Direct
Bicara Therapeutics Inc. Director Stock Option (Right to Buy) 23,746 09 Jun 2025 Direct

Insider Reports Filed by Kate Haviland

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BPMC Blueprint Medicines Corp 17 Jul 2025 13 $0 4 Chief Executive Officer, Director 21 Jul 2025, 19:47
FULC Fulcrum Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 16:15
BCAX Bicara Therapeutics Inc. 09 Jun 2025 1 $0 4 Director 10 Jun 2025, 16:37
BPMC Blueprint Medicines Corp 01 Apr 2025 4 -$216,461 4 CHIEF EXECUTIVE OFFICER, Director 03 Apr 2025, 16:30
BPMC Blueprint Medicines Corp 05 Mar 2025 1 -$1,434,209 4 CHIEF EXECUTIVE OFFICER 07 Mar 2025, 16:08
BPMC Blueprint Medicines Corp 01 Mar 2025 2 $0 4 CHIEF EXECUTIVE OFFICER 04 Mar 2025, 17:19
BPMC Blueprint Medicines Corp 21 Jan 2025 1 -$159,407 4 CHIEF EXECUTIVE OFFICER 23 Jan 2025, 19:56
BPMC Blueprint Medicines Corp 29 Nov 2024 3 -$227,304 4 CHIEF EXECUTIVE OFFICER 03 Dec 2024, 17:33
BCAX Bicara Therapeutics Inc. 12 Sep 2024 1 $0 4 Director 16 Sep 2024, 16:38
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Director 12 Sep 2024, 21:00
FULC Fulcrum Therapeutics, Inc. 17 Jun 2024 1 $0 4 Director 18 Jun 2024, 16:20
BPMC Blueprint Medicines Corp 07 Mar 2024 1 -$1,130,360 4 CHIEF EXECUTIVE OFFICER 11 Mar 2024, 18:27
BPMC Blueprint Medicines Corp 01 Mar 2024 2 $0 4 CHIEF EXECUTIVE OFFICER 06 Mar 2024, 16:18
FULC Fulcrum Therapeutics, Inc. 27 Jun 2023 1 $0 4 Director 29 Jun 2023, 16:16
BPMC Blueprint Medicines Corp 06 Mar 2023 2 -$303,354 4 CHIEF EXECUTIVE OFFICER 08 Mar 2023, 20:24
BPMC Blueprint Medicines Corp 01 Mar 2023 2 $0 4 CHIEF EXECUTIVE OFFICER 03 Mar 2023, 19:07
BPMC Blueprint Medicines Corp 03 Nov 2022 1 +$48,378 4 CHIEF EXECUTIVE OFFICER 07 Nov 2022, 15:07
FULC Fulcrum Therapeutics, Inc. 27 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:00
BPMC Blueprint Medicines Corp 03 Mar 2022 2 -$162,481 4 CHIEF OPERATING OFFICER 08 Mar 2022, 15:05
BPMC Blueprint Medicines Corp 01 Mar 2022 2 $0 4 CHIEF OPERATING OFFICER 03 Mar 2022, 19:07
BPMC Blueprint Medicines Corp 13 Dec 2021 6 -$62,246 4 Chief Operating Officer 15 Dec 2021, 15:23
BPMC Blueprint Medicines Corp 13 Sep 2021 7 -$63,886 4 Chief Operating Officer 15 Sep 2021, 16:13
BPMC Blueprint Medicines Corp 28 Jun 2021 5 -$54,188 4 Chief Operating Officer 30 Jun 2021, 16:02
FULC Fulcrum Therapeutics, Inc. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 17:10